“Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression”, CBS Int. Journal, vol. 1, no. 2, pp. 65–69, Sep. 2022, doi: 10.59278/cbs.v1i2.19.